About

Professor Steven Gill, Founder and Chief Scientific Officer of Neurochase, is an expert in drug delivery strategies for the central nervous system (CNS). An eminent neurosurgeon with over 30 years of experience, he has led multiple preclinical and clinical trials proving out the potential of convection-enhanced delivery and gene therapies.

Professor Gill is also a prolific inventor of medical technology, including the Prestige Cervical joint (Medtronic), and has pioneered deep brain stimulation of novel targets in the brain. He is an industry-leading expert on the delivery of novel therapeutics to the CNS and frequently consults with key decision-makers from many of the world’s biggest pharmaceutical and biotech organisations.